Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
26 SEK | +2,77 % | +11,59 % | +37,13 % |
30/04 | BioInvent anuncia que evaluará la tecnología de Attana | CI |
24/04 | BioInvent International AB (publ) presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
Resumen de negocios
Número de empleados: 109
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 326 | 100,0 % | 71 | 100,0 % | -78,09 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
66,3
%
| 273 | 83,8 % | 47 | 66,3 % | -82,66 % |
Sweden
25,6
%
| 26 | 7,9 % | 18 | 25,6 % | -28,75 % |
Europe
4,1
%
| 27 | 8,3 % | 3 | 4,1 % | -89,11 % |
Other Countries
4,0
%
| - | - | 3 | 4,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 01/09/18 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 01/01/98 |
Marie Moores
COO | Chief Operating Officer | - | 01/02/22 |
Björn Frendéus
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/01/01 |
Chief Tech/Sci/R&D Officer | 68 | 01/01/17 | |
Investor Relations Contact | - | 01/02/21 | |
Emma Meurling
HRO | Human Resources Officer | - | - |
General Counsel | - | 12/06/23 | |
Corporate Officer/Principal | - | 09/06/22 | |
Corporate Officer/Principal | 50 | 01/01/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01/01/18 |
Leonard Kruimer
CHM | Chairman | 66 | 12/05/16 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 12/05/16 |
Thomas O. Hecht
BRD | Director/Board Member | 73 | 03/07/20 |
Erik Esveld
BRD | Director/Board Member | - | 29/04/21 |
Director/Board Member | 49 | 12/07/22 | |
Director/Board Member | 56 | 01/01/18 | |
Natalie Berner
BRD | Director/Board Member | 34 | 12/07/22 |
Martin Pålsson
BRD | Director/Board Member | 45 | 01/01/22 |
Elin Birgersson
BRD | Director/Board Member | 39 | 01/01/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 65 804 362 | 57 013 147 ( 86,64 %) | 0 | 86,64 % |
Información de la empresa
BioInvent International AB
The Gamma Building Ideongatan 1
223 70, Lund
+46 4 62 86 85 50
http://www.bioinvent.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,13 % | 156 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-15,84 % | 21,4 mil M | |
-10,21 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-14,65 % | 16,09 mil M | |
+4,39 % | 13,83 mil M | |
+31,35 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción BINV
- Empresa BioInvent International AB